Document Detail


Pharmacokinetic/pharmacodynamic modeling and simulation to determine effective dosage regimens for doripenem.
MedLine Citation:
PMID:  19904828     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of this study was to obtain information on effective dosage regimens of doripenem by a modeling and simulation approach based on pharmacokinetic (PK)/pharmacodynamic (PD) theory. The PK/PD model we have already developed was modified to explain in vitro bactericidal kinetics of doripenem for several Pseudomonas aeruginosa strains. Time-course profiles of bacterial counts in patients infected with P. aeruginosa were simulated for typical clinical dosage regimens in Japan considering the variability of PK and the patients' backgrounds by a Monte Carlo simulation. Moreover, time-course profiles of probability achieving the criterion (log(CFU/mL) < 0) were predicted for the evaluation of antibacterial efficacy by renal function. The in vitro bacterial profiles at various dosage regimens could be well explained by the PK/PD model. The simulations suggested the dependence of antibacterial efficacy on the frequency of administration, indicating time-dependent antibacterial activity. It was also suggested that 500 mg t.i.d. showed significant bacterial reduction in patients for any degree of renal function and any severities in 2 weeks after the start of treatment. Our approach to simulate time-course profiles of bacterial counts should be useful for determining and examining effective dosage regimens, including the treatment period, in drug development.
Authors:
Takayuki Katsube; Yoshitaka Yano; Toshihiro Wajima; Yoshinori Yamano; Mikihisa Takano
Related Documents :
16810558 - Diazepam pharamacokinetics from preclinical to phase i using a bayesian population phys...
3199318 - Linear and nonlinear system approaches in pharmacokinetics: how much do they have to of...
6441198 - Simulations of methylene chloride pharmacokinetics using a physiologically based model.
10201688 - Recirculatory and compartmental pharmacokinetic modeling of alfentanil in pigs: the inf...
7068908 - Granulocyte chemotaxis: multiple assay screening using a raft technique.
3189528 - Isolation by distance on the island of korcula: correlation analysis of distance measures.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of pharmaceutical sciences     Volume:  99     ISSN:  1520-6017     ISO Abbreviation:  J Pharm Sci     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-03-16     Completed Date:  2010-06-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985195R     Medline TA:  J Pharm Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2483-91     Citation Subset:  IM    
Affiliation:
Clinical Research Department, Shionogi & Co., Ltd, Sagisu 5-12-4, Fukushima-ku, Osaka 553-0002, Japan. takayuki.katsube@shionogi.co.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Bacterial Agents* / administration & dosage,  pharmacokinetics,  pharmacology
Carbapenems* / administration & dosage,  pharmacokinetics,  pharmacology
Computer Simulation
Dose-Response Relationship, Drug
Drug Administration Schedule
Microbial Sensitivity Tests
Models, Biological*
Monte Carlo Method
Pseudomonas aeruginosa / drug effects
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Carbapenems; 0/doripenem

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Liposomes with high encapsulation capacity for paclitaxel: Preparation, characterisation and in vivo...
Next Document:  NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neuro...